Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Roy S, Sun Y, Hussain M, Chi KN, Fizazi K, Davis ID, Halabi S, Agarwal N, Chowdhury S, Tombal B, Morgan SC, Malone S, Barata PC, Ong M, Wallis CJD, Berlin A, Swami U, Kishan AU, Jia AY, Zaorsky NG, Garcia JA, Mendiratta P, Brown JR, Subhash VV, Stockler MR, Thomas H, McKay RR, Small EJ, Shore ND, Saad F, Sweeney CJ, Spratt DE

Open source

DOI: 10.1038/s41467-025-67298-z
Published: 2025 Dec 17
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-67298-z,
  title = {Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.},
  author = {Roy S and Sun Y and Hussain M and Chi KN and Fizazi K and Davis ID and Halabi S and Agarwal N and Chowdhury S and Tombal B and Morgan SC and Malone S and Barata PC and Ong M and Wallis CJD and Berlin A and Swami U and Kishan AU and Jia AY and Zaorsky NG and Garcia JA and Mendiratta P and Brown JR and Subhash VV and Stockler MR and Thomas H and McKay RR and Small EJ and Shore ND and Saad F and Sweeney CJ and Spratt DE},
  year = {2025},
  journal = {Nature communications},
  doi = {10.1038/s41467-025-67298-z},
  url = {https://doi.org/10.1038/s41467-025-67298-z}
}

RIS

TY  - JOUR
TI  - Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.
AU  - Roy S
AU  - Sun Y
AU  - Hussain M
AU  - Chi KN
AU  - Fizazi K
AU  - Davis ID
AU  - Halabi S
AU  - Agarwal N
AU  - Chowdhury S
AU  - Tombal B
AU  - Morgan SC
AU  - Malone S
AU  - Barata PC
AU  - Ong M
AU  - Wallis CJD
AU  - Berlin A
AU  - Swami U
AU  - Kishan AU
AU  - Jia AY
AU  - Zaorsky NG
AU  - Garcia JA
AU  - Mendiratta P
AU  - Brown JR
AU  - Subhash VV
AU  - Stockler MR
AU  - Thomas H
AU  - McKay RR
AU  - Small EJ
AU  - Shore ND
AU  - Saad F
AU  - Sweeney CJ
AU  - Spratt DE
PY  - 2025
JO  - Nature communications
DO  - 10.1038/s41467-025-67298-z
UR  - https://doi.org/10.1038/s41467-025-67298-z
ER  -

APA

S, R., Y, S., M, H., KN, C., K, F., ID, D., S, H., N, A., S, C., B, T., SC, M., S, M., PC, B., M, O., CJD, W., A, B., U, S., AU, K., AY, J., NG, Z., JA, G., P, M., JR, B., VV, S., MR, S., H, T., RR, M., EJ, S., ND, S., F, S., CJ, S., & DE, S. (2025). Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.. Nature communications. https://doi.org/10.1038/s41467-025-67298-z

Source records

pubmed · retrieved 2026-09-27T12:09:53.462Z